Vivo Capital LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vivo Capital LLC
CRD #159868
SEC #801-79829
CIK #0001674712, 0000167471
AUM $5.3 B (2025-03-31)
Employees 67 (58% Investors, 0% Brokers)
Phone650-688-0818
Address192 Lytton Avenue
Palo Alto, CA 94301
Source [IAPD] [EDGAR] [Website] [LinkedIn] [Facebook] [Instagram]
Total AUM ($B)
7.56.04.53.01.50.02011201620212026
CIK Period
0001674712 0000167471
Sector Form 13F Holdings Value ($B)
Capnia Inc 0.3
Verona Pharma PLC 0.1
Cidara Therapeutics Inc 0.1
Geron Corp 0.0
Oric Pharmaceuticals Inc 0.0
Terns Pharmaceuticals Inc 0.0
Trevi Therapeutics Inc 0.0
Flamel Technologies Sa 0.0
Akero Therapeutics Inc 0.0
Olivia Ventures Inc 0.0
Signal Genetics Inc 0.0
CytomX Therapeutics Inc 0.0
Aclaris Therapeutics Inc 0.0
Zenas Biopharma Inc 0.0
Dyne Therapeutics Inc 0.0
Access Pharmaceuticals Inc 0.0
DBV Technologies Sa 0.0
Talaris Therapeutics Inc 0.0
FITS My Style Inc 0.0
Compass Pathways PLC 0.0
Corvus Pharmaceuticals Inc 0.0
Erasca Inc 0.0
IO Biotech Inc 0.0
Catabasis Pharmaceuticals Inc 0.0
Celcuity Inc 0.0
UNUM Therapeutics Inc 0.0
Delcath Systems Inc 0.0
Praxis Precision Medicines Inc 0.0
Bright Minds Biosciences Inc 0.0
Olema Pharmaceuticals Inc 0.0
Prev | Page 1 | Next
Type Form D Funds Date Sold ($M) AUM ($M)
PE Vivo Arrace Fund LP [2025-03-31] 0.0 278.2
Other Vivo Asia Spring Limited 2025-03-31 10.0
PE Vivo Capital Fund X LP [2024-03-28] 707.0 754.5
PE Vivo Co-Invest C LP [2024-03-28] 0.0 150.0
Other Vivo Asia Opportunity Fund Holdings LP [2023-03-31] 148.5 89.7
VC Vivo Co-Invest S LP [2023-03-31] 0.0 49.9
VC Vivo Innovation Fund II Holdings LP [2023-03-31] 0.0 329.1
Other Vivo Opportunity Fund Holdings LP [2023-03-31] 634.6 1,128.5
PE Vivo Asia Opportunity Fund LP [2022-03-31] 148.5 105.4
VC Vivo Innovation Fund II LP [2021-03-31] 180.0 209.0
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 17 5.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 17 5.3
By Discretionary
Discretionary 17 5.3
Non-Discretionary 0 0.0
Total 17 5.3
By Non-United States Persons
Non-United States Persons 0.3
United States Persons 5.0
Total 17 5.3
Limited Partners2011 - 2025
California State Teachers' Retirement System
Form D Directors # Filings # Firms 2011 - 2025
Chen Yu 24
Gaurav Aggarwal 18
Albert Cha 45
Jack Nielsen 44
Frank Kung 44
Michael Chang 36
Edgar Engleman 29
Mahendra Shah 26
Hongbo Lu 17
David Liu 15
View All
EDGAR Form CIK 2011 - 2025
13F-HR [0001674712]
3 [0001674712]
4 [0001674712]
SC 13D [0001674712]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vivo Capital LLC Sinovac Biotech Ltd [2018-07-11]
Form 3/4/5 Subject 2011 - 2025
Vivo Capital, LLC
Vivo Capital Fund VIII, L.P.
Vivo Capital Surplus Fund VIII, L.P.
Vivo Opportunity Fund, L.P.
Vivo Capital VIII, LLC
Vivo Opportunity, LLC
Crinetics Pharmaceuticals, Inc.
Comparable Firms State AUM ($B)
Siris Capital Group LLC
NY 5.4
JLL Partners LLC
NY 5.4
BV Investment Partners LP
MA 5.4
Flexstone Partners LLC
NY 5.3
Level Equity Management LLC
NY 5.3
Silversmith Management LP
MA 5.3
Cornell Capital LLC
NY 5.3
Lee Equity Partners LLC
NY 5.3
Serent Capital Management Company LLC
CA 5.2
Gallatin Point Capital LLC
CT 5.2
Terms | Privacy | Guide
tony@aum13f.com